Bio-Repository

 

The Vancouver Prostate Centre has a tumour bank that contains well over 3000 prostate, bladder, kidney and testicular tumour specimens (both fresh frozen and paraffin embedded). This tumour bank has an integrated database that is overseen by a full-time coordinator, along with a full-time research pathologist and staff.

Resources

The Vancouver Prostate Centre’s collection includes the world’s largest repository of the following:

  • pre- and post-treated urogenital tumours
  • tumours stratified from low to high risk (matched primary and metastatic tumours)
  • treatment resistant cancers fully annotated for previous therapies, responses, stage and prognostic indicators, biomarkers etc.

An established bank of more than 700 human radical prostatectomy specimens stored at -156 degrees centigrade and in paraffin blocks

More than 1,000 archived prostatectomy specimens from patients with no prior hormone therapy or after variable periods of pre-treatment with one, three, or eight months of neo-adjuvant hormone therapy prior to surgery.

The VPC has also constructed the following:

  • Tissue microarrays (TMAs) from post-treated cancer specimens that are useful for high throughput validation of transcriptional profiles.
  • TMAs spotted with control normal prostate tissue together with more than 400 individual samples from benign, and Gleason grades of  1 to 5 all linked to clinical correlative data and PSA recurrence rate status.
  • A TMA with rare tumours of NEPC and CRPC TURP specimen.
  • A unique post-hormone therapy treated TMA consisting of a total of 336 cores from 112 patients treated with no hormone therapy (21), 3-6 (49), and more than 8 (28) months of neo-adjuvant hormone therapy prior to radical prostatectomy, and 14 patients with metastatic castrate resistant prostate cancer.
  • TMAs from patients entered into the Canadian Uro-Oncology Group randomized comparative study of 3 vs 8 months of neo-adjuvant hormone therapy, as well as from a multicentre Phase II trial of 70 patients treated with neo-adjuvant hormone plus docetaxel, all with annotated clinical and pathological correlates.
  • Various TMAs from bladder and kidney tumours before and after treatment.

Background

The Vancouver Prostate Centre has been collecting human human urological tumours for well over 20 years. The process of collecting and bio-banking these specimens has been undertaken with an institutionally approved consent form and each individual specimen has been consented for research purposes within the institution. VPC implements high ethical standards to protect patient’s confidentiality in this process.

All the experiments conformed to the principle of University of British Columbia, Office of Research Ethics, Clinical Research Ethics Board, with assigned UBC CREB NUMBER.

The CREB procedures/policies correspond to, and therefore comply with the ethical principles that were developed in the Declaration of Helsinki.

Updated: April 9, 2021

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Conference Flyer Page 1

Breast & Prostate Cancer half-day virtual conference: Saturday, September 18th, 2021

The What you Need to Know for Your Patients Post Breast & Prostate Cancer Conference, taking place online on Saturday, September 18th, 2021 from 8:00am – 1:30pm, is an accredited virtual half-day conference focusing on screening, treatment, side-effect management & emerging new therapies for breast & prostate cancer patients. Click here for more information and to register. 

Dr. Peter Black, team captain

Terry Fox Run fundraiser: September 19th, 2021

The 41st Annual Terry Fox Run is taking place on Sunday September 19, 2021. If you are able, please consider donating to our team (tax receipts issued), raising funds for the Terry Fox Foundation's ground-breaking cancer research. 

Employment

Work at the Vancouver Prostate Centre

Wednesday, September 8, 2021

Recent publication proposes a potential new therapeutic approach to treatment-resistant prostate cancer

Tuesday, August 3, 2021

Dr. Cherkasov receives 2021 Faculty of Medicine Distinguished Achievement Award

Dr. Cherkasov